Lin, C.-H., Chen, J.-K., Ko, T.-M., Wei, C.-Y., Wu, J.-Y., Chung, W.-H., … Chen, Y.-T. (2015). Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol, 135(4), 1063-1065.e5. https://doi.org/10.1016/j.jaci.2014.09.041

Lin, Chia-Hsien, Jung-Kuei Chen, Tai-Ming Ko, Chun-Yu Wei, Jer-Yuarn Wu, Wen-Hung Chung, Shih-Yang Chen, You-Di Liao, Shuen-Iu Hung, and Yuan-Tsong Chen. “Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction.” J Allergy Clin Immunol 135, no. 4 (April 2015): 1063-1065.e5. https://doi.org/10.1016/j.jaci.2014.09.041.

Lin C-H, Chen J-K, Ko T-M, Wei C-Y, Wu J-Y, Chung W-H, et al. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol. 2015 Apr;135(4):1063-1065.e5.

Lin, Chia-Hsien, et al. “Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction.” J Allergy Clin Immunol, vol. 135, no. 4, Apr. 2015, pp. 1063-1065.e5. Pubmed, doi:10.1016/j.jaci.2014.09.041.

Lin C-H, Chen J-K, Ko T-M, Wei C-Y, Wu J-Y, Chung W-H, Chen S-Y, Liao Y-D, Hung S-I, Chen Y-T. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol. 2015 Apr;135(4):1063-1065.e5.